SLC5A2 and hydrops fetalis: However, as clearly stated in the previous section of the present comprehensive review of the relevant literature, it cannot be deduced based on current evidence that SGLT-2 inhibitors provide a significant effect on surrogate endpoints in acute HF, namely in all-cause mortality and worsening HF.